Clinical parameters associated with collateral development in patients with chronic total coronary occlusion

Heart

Volumn 99, Issue 15, 2013, Pages 1100-1105

  Van Der Hoeven, N W ^a   Teunissen, P F ^a   Werner, G S ^b   Delewi, R ^c   Schirmer, S H ^d   Traupe, T ^e   Van Der Laan, A M ^c   Tijssen, J G ^c   Piek, J J ^c   Seiler, C ^e   Van Royen, N ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KLINIKUM DARMSTADT   (Germany)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d SAARLAND UNIVERSITY   (Germany)

^e UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; ANGIOGENESIS; AORTA PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR PARAMETERS; CENTRAL VENOUS PRESSURE; CHRONIC TOTAL OCCLUSION; COLLATERAL FLOW INDEX; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY OBSTRUCTION; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

CORONARY ARTERY DISEASE;

ADRENERGIC BETA-ANTAGONISTS; AGED; ARTERIAL PRESSURE; CENTRAL VENOUS PRESSURE; COHORT STUDIES; COLLATERAL CIRCULATION; COMORBIDITY; CORONARY CIRCULATION; CORONARY OCCLUSION; CORONARY VESSELS; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; FEMALE; GERMANY; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE CARE; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; SWITZERLAND;

EID: 84880118131     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-304006     Document Type: Article

References (56)

1. Meier P, Gloekler S, Zbinden R, et al. Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation 2007;116:975-83. (Pubitemid 47329562)
2. van der Laan AM, Schirmer SH, de Vries MR, et al. Galectin-2 expression is dependent on the rs7291467 polymorphism and acts as an inhibitor of arteriogenesis. Eur Heart J 2011;33:10-84.
3. Teunissen PF, Horrevoets AJ, van Royen N. The coronary collateral circulation: Genetic and environmental determinants in experimental models and humans. J Mol Cell Cardiol 2012;52:897-904.
4. Azhar G, Gao W, Liu L, et al. Ischemia-reperfusion in the adult mouse heart influence of age. Exp Gerontol 1999;34:699-714. (Pubitemid 29420332)
5. Nakae I, Fujita M, Miwa K, et al. Age-dependent impairment of coronary collateral development in humans. Heart Vessels 2000;15:176-80. (Pubitemid 32573966)
6. Kurotobi T, Sato H, Kinjo K, et al. Reduced collateral circulation to the infarct-related artery in elderly patients with acute myocardial infarction. J Am Coll Cardiol 2004;44:28-34. (Pubitemid 38968451)
7. van Royen N, Hoefer I, Buschmann I, et al. Effects of local MCP-1 protein therapy on the development of the collateral circulation and atherosclerosis in Watanabe hyperlipidemic rabbits. Cardiovasc Res 2003;57:178-85. (Pubitemid 36009449)
8. Kornowski R. Collateral formation and clinical variables in obstructive coronary artery disease: the influence of hypercholesterolemia and diabetes mellitus. Coron Artery Dis 2003;14:61-4. (Pubitemid 36337818)
9. Boodhwani M, Nakai Y, Mieno S, et al. Hypercholesterolemia impairs the myocardial angiogenic response in a swine model of chronic ischemia: role of endostatin and oxidative stress. Ann Thorac Surg 2006;81:634-41. (Pubitemid 43120569)
10. Abaci A, Oguzhan A, Kahraman S, et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999;99:2239-42. (Pubitemid 29201128)
11. Zbinden R, Zbinden S, Billinger M, et al. Influence of diabetes mellitus on coronary collateral flow: an answer to an old controversy. Heart 2005;91:1289-93. (Pubitemid 41360943)
12. Di Carli MF, Janisse J, Grunberger G, et al. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 2003;41:1387-93. (Pubitemid 36439001)
13. Dincer I, Ongun A, Turhan S, et al. Association between the dosage and duration of statin treatment with coronary collateral development. Coron Artery Dis 2006;17:561-5. (Pubitemid 44231685)
14. Kyriakides ZS, Kolettis T, Antoniadis A, et al. Beta-adrenergic blockade decreases coronary collateral blood flow in patients with coronary artery disease. Cardiovasc Drugs Ther 1998;12:551-9. (Pubitemid 29123635)
15. Pohl T, Seiler C, Billinger M, et al. Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease. J Am Coll Cardiol 2001;38:1872-8. (Pubitemid 33116557)
16. Meier P, Antonov J, Zbinden R, et al. Non-invasive gene-expression-based detection of well-developed collateral function in individuals with and without coronary artery disease. Heart 2009;95:900-8.
17. Jensen LO, Thayssen P, Lassen JF, et al. Recruitable collateral blood flow index predicts coronary instent restenosis after percutaneous coronary intervention. Eur Heart J 2007;28:1820-6. (Pubitemid 47240956)
18. Harmouche M, Maasrani M, Corbineau H, et al. A more sensitive pressure-based index to estimate collateral blood supply in case of coronary three-vessel disease. Med Hypotheses 2012;79:261-3.
19. Seiler C, Fleisch M, Garachemani A, et al. Coronary collateral quantitation in patients with coronary artery disease using intravascular flow velocity or pressure measurements. J Am Coll Cardiol 1998;32:1272-9. (Pubitemid 28522383)
20. Piek JJ, Koolen JJ, Hoedemaker G, et al. Severity of single-vessel coronary arterial stenosis and duration of angina as determinants of recruitable collateral vessels during balloon angioplasty occlusion. Am J Cardiol 1991;67:13-17.
21. Piek JJ, van Liebergen RA, Koch KT, et al. Clinical, angiographic and hemodynamic predictors of recruitable collateral flow assessed during balloon angioplasty coronary occlusion. J Am Coll Cardiol 1997;29:275-82. (Pubitemid 27059955)
22. Rentrop KP, Thornton JC, Feit F, et al. Determinants and protective potential of coronary arterial collaterals as assessed by an angioplasty model. Am J Cardiol 1988;61:677-84. (Pubitemid 18089274)
23. Gensini GG, Bruto da Costa BC. The coronary collateral circulation in living man. Am J Cardiol 1969;24:393-400.
24. Kramer DS, Criley JM. Dynamic nature of coronary collateral blood flow. Am J Cardiol 1985;56:994-5. (Pubitemid 16126788)
25. Helfant RH, Vokonas PS, Gorlin R. Functional importance of the human coronary collateral circulation. N Engl J Med 1971;284:1277-81.
26. Paclik D, Werner L, Guckelberger O, et al. Galectins distinctively regulate central monocyte and macrophage function. Cell Immunol 2011;271:97-103.
27. Bach RG, Donohue TJ, Caracciolo EA, et al. Quantification of collateral blood flow during PTCA by intravascular Doppler. Eur Heart J 1995;16(Suppl J):74-7.
28. Kern MJ, Donohue TJ, Bach RG, et al. Quantitating coronary collateral flow velocity in patients during coronary angioplasty using a Doppler guidewire. Am J Cardiol 1993;71:34D-40D. (Pubitemid 23149638)
29. Tron C, Donohue TJ, Bach RG, et al. Differential characterization of human coronary collateral blood flow velocity. Am Heart J 1996;132:508-15. (Pubitemid 26347753)
30. Yamada T, Okamoto M, Sueda T, et al. Relation between collateral flow assessed by Doppler guide wire and angiographic collateral grades. Am Heart J 1995;130:32-7.
31. de Marchi SF, Gloekler S, Meier P, et al. Determinants of preformed collateral vessels in the human heart without coronary artery disease. Cardiology 2011;118:198-206.
32. Kilian JG, Keech A, Adams MR, et al. Coronary collateralization: determinants of adequate distal vessel filling after arterial occlusion. Coron Artery Dis 2002;13:155-9. (Pubitemid 34747963)
33. Sodha NR, Clements RT, Boodhwani M, et al. Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation. Am J Physiol Heart Circ Physiol 2009;296:H428-34.
34. Lin TH, Wang CL, Su HM, et al. Functional vascular endothelial growth factor gene polymorphisms and diabetes: effect on coronary collaterals in patients with significant coronary artery disease. Clin Chim Acta 2010;411:1688-93.
35. Kadi H, Ceyhan K, Karayakali M, et al. Effects of prediabetes on coronary collateral circulation in patients with coronary artery disease. Coron Artery Dis 2011;22:233-7.
36. Kyriakides ZS, Kremastinos DT, Michelakakis NA, et al. Coronary collateral circulation in coronary artery disease and systemic hypertension. Am J Cardiol 1991;67:687-90.
37. Kureishi Y, Luo Z, Shiojima I, et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 2000;6:1004-10.
38. Pourati I, Kimmelstiel C, Rand W, et al. Statin use is associated with enhanced collateralization of severely diseased coronary arteries. Am Heart J 2003;146:876-81. (Pubitemid 37378578)
39. Mallet RT, Ryou MG, Williams AG Jr, et al. Beta1-Adrenergic receptor antagonism abrogates cardioprotective effects of intermittent hypoxia. Basic Res Cardiol 2006;101:436-46. (Pubitemid 44275877)
40. Asanuma H, Minamino T, Sanada S, et al. Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts. Circulation 2004;109:2773-9. (Pubitemid 38737925)
41. Lee JY, Huo TI, Huang HC, et al. Propranolol modulates the collateral vascular responsiveness to vasopressin via a G(alpha)-mediated pathway in portal hypertensive rats. Clin Sci (Lond) 2011;121:545-54.
42. Billinger M, Raeber L, Seiler C, et al. Coronary collateral perfusion in patients with coronary artery disease: effect of metoprolol. Eur Heart J 2004;25:565-70. (Pubitemid 38478549)
43. Togni M, Vigorito F, Windecker S, et al. Does the beta-blocker nebivolol increase coronary flow reserve? Cardiovasc Drugs Ther 2007;21:99-108. (Pubitemid 46834904)
44. Patel SR, Breall JA, Diver DJ, et al. Bradycardia is associated with development of coronary collateral vessels in humans. Coron Artery Dis 2000;11:467-72. (Pubitemid 30663858)
45. Schirmer SH, Degen A, Baumhakel M, et al. Heart-rate reduction by If-channel inhibition with ivabradine restores collateral artery growth in hypercholesterolemic atherosclerosis. Eur Heart J 2011;33:1223-31.
46. van der Pouw Kraan TC, Snijders A, Boeije LC, et al. Histamine inhibits the production of interleukin-12 through interaction with H2 receptors. J Clin Invest 1998;102:1866-73. (Pubitemid 28533834)
47. van der Pouw Kraan TC, Boeije LC, Smeenk RJ, et al. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med 1995;181:775-9.
48. van der Poll T, Coyle SM, Barbosa K, et al. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 1996;97:713-19. (Pubitemid 26057090)
49. van der Poll T, Lowry SF. Epinephrine inhibits endotoxin-induced IL-1 beta production: roles of tumor necrosis factor-alpha and IL-10. Am J Physiol 1997;273 (6 Pt 2):R1885-90.
50. Bakker EN, Matlung HL, Bonta P, et al. Blood flow-dependent arterial remodelling is facilitated by inflammation but directed by vascular tone. Cardiovasc Res 2008;78:341-8. (Pubitemid 351556108)
51. Amano K, Okigaki M, Adachi Y, et al. Mechanism for IL-1 beta-mediated neovascularization unmasked by IL-1 beta knock-out mice. J Mol Cell Cardiol 2004;36:469-80. (Pubitemid 38469938)
52. Rentrop KP, Feit F, Sherman W, et al. Late thrombolytic therapy preserves left ventricular function in patients with collateralized total coronary occlusion: primary end point findings of the Second Mount Sinai-New York University Reperfusion Trial. J Am Coll Cardiol 1989;14:58-64. (Pubitemid 19165536)
53. van Royen N, Piek JJ, Buschmann I, et al. Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease. Cardiovasc Res 2001;49:543-53. (Pubitemid 32146417)
54. Schirmer SH, van Nooijen FC, Piek JJ, et al. Stimulation of collateral artery growth: travelling further down the road to clinical application. Heart 2009;95:191-7.
55. Kocaman SA, Yalcin MR, Yagci M, et al. Endothelial progenitor cells (CD34+KDR+) and monocytes may provide the development of good coronary collaterals despite the vascular risk factors and extensive atherosclerosis. Anadolu Kardiyol Derg 2011;11:290-9.
56. Takeda Y, Costa S, Delamarre E, et al. Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature 2011;479:122-6.